Amanote Research
Register
Sign In
Different Values in Cost-Effectiveness Research: Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.09.897
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2016
Authors
D Liden
A Jaksa
Publisher
Elsevier BV
Related search
Utility Values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Is National Institute of Clinical Excellence (NICE) Guideline a Nice Guideline?
Translational Andrology and Urology
Reproductive Medicine
Urology
National Institute for Health and Clinical Excellence
Journal of Neonatal Nursing
Pediatrics
Midwifery
Maternity
Php295 - Review of Possible Causes of Variation in National Institute for Health and Care Excellence (Nice) Technology Appraisals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php272 - Quantitative Assessment of Technical Errors Found in Economic Models Submitted to the National Institute for Health and Care Excellence (Nice)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php294 - A Review of Recent Appraisals From the Institute for Clinical and Economic Review: How Important Is the Icer?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Urological Recommendations From the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected Cancer: Recognition and Referral
BJU International
Urology
PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Multiple Sclerosis and the Comparative Value Disease Modifying Therapy Report of the Institute for Clinical and Economic Review (ICER)
INNOVATIONS in pharmacy
